StockWatch
·

AMRUTANJAN HEALTH CARE LTD.-$ Q2 FY27 Results

AMRUTANJANQ2 FY27 Results
Filing
Result:Good· Market: Up#Margin expansion#Turnaround
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue135.1831.3%14.8%
Total Income138.2029.4%13.3%
Expenditure115.1016.6%12.0%
PBT23.10280.5%20.2%
Net Profit17.28295.8%23.8%
OPM17.47%13.38pp3.43pp
NPM12.50%8.41pp1.06pp
EPS5.98296.0%23.8%
View full financials

Pharma/consumer-health peer: core revenue growth of 14.9% YoY is solid and adjusted PAT grew 23.8% YoY on genuine margin expansion (OTC strength plus Women's Hygiene turnaround), not one-offs, though the Beverages segment drag and modest base keep it just shy of a standout.

Q2 FY-2027 RESULTS · AMRUTANJAN

Amrutanjan Q2 FY27: PAT up 24% YoY to ₹17.3 Cr as margins expand, hygiene turns profitable

PAT +23.77% YoY · revenue +14.85% · margins expanding

03 Nov 2026 · 3 min read
Revenue

₹135.18 Cr

+14.85% YoY

PAT (standalone)

₹17.28 Cr

+23.77% YoY

Net margin

12.5%

+1.1pp YoY

EPS

₹5.98

Amrutanjan's standalone revenue from operations rose 14.9% YoY to ₹135.18 Cr in Q2 FY27 (quarter ended 30 September 2026), while net profit grew faster at 23.8% YoY to ₹17.28 Cr, lifting net profit margin to 12.78% from 11.86% a year earlier. Both the current and year-ago quarters are clean of exceptional items, so this YoY comparison is like-for-like — unlike the sequential print, where Q1 FY27 (June quarter) carried a ₹2.03 Cr exceptional charge (one-time settlement of a decades-old Tamil Nadu lease-rent dispute) that depressed that quarter's PAT to ₹4.37 Cr. The resulting +296% QoQ PAT jump is a base-effect artifact of that one-off and should not be read as the quarter's story; the 14.9% revenue / 23.8% PAT YoY print is the cleaner read.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹135.18 Cr+31.3%+14.9%
Expenses₹115.1 Cr+16.6%+12%
PAT₹17.28 Cr+295.84%+23.77%
Net margin12.5%+8.4pp+1.1pp
EPS₹5.98+296%+23.8%

The margin expansion was driven by the core OTC portfolio and a turnaround in Women's Hygiene & Personal Care: OTC segment profit rose 26.5% YoY to ₹23.29 Cr on revenue of ₹90.94 Cr (+13.7% YoY), while Women's Hygiene swung to a ₹0.46 Cr segment profit from a ₹1.26 Cr loss a year ago and a ₹2.88 Cr loss last quarter — its first profitable quarter in this comparison window. Operating margin (ex-other income, ex-exceptional items) expanded to 14.85% from 12.68% YoY. Beverages was the drag: revenue fell 29.4% YoY to ₹3.03 Cr and its segment loss widened to ₹2.41 Cr from ₹0.65 Cr a year ago, continuing a decline already visible last quarter. The effective tax rate also eased to 25.2% from 27.3% YoY, helping PAT growth outpace PBT growth of 20.2% YoY.

₹
478.84494.76510.68526.59542.51498.3507-3108-2409-1610-0911-03Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹498.35, down 3.4% over the past month of trading.

₹ Cr
07.2614.5221.798.31Q1 FY26rev ₹94 Cr13.96Q2 FY26rev ₹118 Cr19.45Q3 FY26rev ₹141 Cr16.19Q4 FY26rev ₹150 Cr4.37Q1 FY27rev ₹103 Cr17.28Q2 FY27rev ₹135 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters.

No analyst consensus or brokerage preview for this quarter surfaced in a web search, and the company has issued no formal forward guidance in our records or online, so there is no external yardstick this print beat or missed — both vsStreet and vsGuidance are unknown. No management press release accompanied this filing. Alongside the results, the board declared a First Interim Dividend of ₹1 per share for FY27, consistent with its regular payout cadence (it had approved a ₹2.90 final dividend for FY26 at the September 2026 AGM).

  • W1

    Whether Women's Hygiene & Personal Care sustains its newly profitable run-rate (₹0.46 Cr in Q2) into Q3 FY27

  • W2

    Beverages segment loss trajectory — widened to ₹2.41 Cr this quarter on a 29.4% revenue decline

  • W3

    Effective tax rate, which eased to 25.2% from 27.3% YoY — confirm whether this level holds

Informational and educational content only. Not investment advice.